-
[1] Cholesterol Treatment Trialists’ (CTT) Collaboration, Baigent C., BlackwellL., Emberson J., Holland L.E., Reith C., Bhala N., Peto R., Barnes E.H., Keech A., Simes J., Collins R., et al., Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet, 2010 , 376(9753), 1670-1681
-
[2] Wenger N., Lewis S.J., et al., Use of statin therapy to reduce cardiovascular risk in older patients. Curr. Gerontol. Geriatr. Res., 2010, 915296
-
[3] Kapur N.K., Musunuru K., et al., Clinical efficacy and safety of statins in managing cardiovascular risk. Vasc. Health Risk Manag., 2008, 4(2), 341-353
-
RELATION NAME
-
[5] Bays H., Statin safety: an overview and assessment of the data-2005. Am. J. Cardiol., 2006, 97(8A), 6C-26C
-
RELATION NAME
-
RELATION NAME
-
RELATION NAME
-
[9] Golomb B.A., Evans M.A., et al., Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism. Am. J. Cardiovasc. Drugs, 2008, 8(6), 373-418
-
RELATION NAME